文献速递病毒性肝炎

IFN-α抑制髓系细胞因子产生,损害IL-12生成及支持T细胞增殖的能力

IFN-α Suppresses Myeloid Cytokine Production, Impairing IL-12 Production and the Ability to Support T-Cell Proliferation.
PubMed 文献 · J Infect Dis · 2020-01-01

该研究探讨IFN-α在体内是否改变人抗原呈递细胞功能。采用健康供者外周血单个核细胞及开始IFN-α治疗的慢性乙型肝炎患者,发现IFN-α上调单核细胞活化标志物却抑制TLR诱导的细胞因子产生和T细胞增殖,且IL-12减少是T细胞增殖受抑的关键机制。

要点

  • IFN-α上调单核细胞HLA-DR、CD80、CD86和PD-L1表达。
  • IFN-α抑制TLR诱导的细胞因子产生及单核细胞诱导的T细胞增殖。
  • 补充IL-12可恢复T细胞增殖至基线水平。

核心结论

  • IFN-α通过抑制IL-12产生而非抑制性受体表达来损害单核细胞支持T细胞增殖的能力。

研究设计与样本

  • 使用健康供者外周血单个核细胞暴露于IFN-α,并纳入开始IFN-α治疗的慢性乙型肝炎患者进行免疫调节效应研究。

主要发现

  • IFN-α增加健康供者单核细胞HLA-DR、CD80、CD86和PD-L1表达。
  • IFN-α抑制Toll样受体诱导的细胞因子产生和单核细胞诱导的T细胞增殖。
  • 慢性乙型肝炎患者接受聚乙二醇干扰素治疗后,单核细胞出现干扰素刺激基因特征并上调HLA-DR、CD80、CD86和PD-L1表达。
  • 慢性乙型肝炎患者开始治疗后最早3天,IFN-α在离体条件下抑制单核细胞细胞因子产生和T细胞刺激。
  • IFN-α介导的IL-12产生抑制而非抑制性受体表达导致T细胞增殖受抑,添加IL-12可恢复T细胞增殖至基线水平。

临床怎么用

  • 理解IFN-α对专职抗原呈递细胞的免疫调节作用,有助于设计新的固有免疫和适应性免疫靶向免疫疗法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interferon-α (IFN-α) can suppress production of T-cell polarizing cytokines or induce inhibitory antigen-presenting cells that suppress T-cell activation. Previous studies showed that IFN-α therapy fails to boost virus-specific T-cell immunity in patients with chronic hepatitis B virus infection. Our aim was to determine whether IFN-α exposure alters human antigen-presenting cell function in vivo. METHODS: We investigated the immunomodulatory effects using peripheral blood mononuclear cells from healthy donors exposed to IFN-α and chronic hepatitis B (CHB) patients starting IFN-α therapy. RESULTS: IFN-α increased HLA-DR, CD80, CD86, and PD-L1 expression on healthy donor monocytes. In contrast to the activated phenotype, IFN-α inhibited Toll-like receptor-induced cytokine production and monocyte-induced T-cell proliferation. In CHB patients, peg-IFN treatment induced an interferon-stimulated gene signature in monocytes and increased HLA-DR, CD80, CD86, and PD-L1 expression. As early as 3 days after CHB patients started treatment, IFN-α inhibited monocyte cytokine production and T-cell stimulation ex vivo. IFN-α-mediated inhibition of IL-12 production, rather than inhibitory receptor expression, was responsible for inhibition of T-cell proliferation. Addition of IL-12 restored T-cell proliferation to baseline levels. CONCLUSIONS: Understanding how professional antigen-presenting cells respond to immunomodulation is important for both new innate and adaptive-targeted immunotherapies. CLINICAL TRIALS REGISTRATION: NCT00962871.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mehrotra A, D'Angelo JA, Romney-Vanterpool A, et al. IFN-α Suppresses Myeloid Cytokine Production, Impairing IL-12 Production and the Ability to Support T-Cell Proliferation. J Infect Dis. 2020. PMID: 32049318. doi:10.1093/infdis/jiaa064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。